Expressing support for the designation of the week of May 4, 2025, through May 10, 2025, as "Tardive Dyskinesia Awareness Week".

HRES 396 designates the week of May 4-10, 2025, as "Tardive Dyskinesia Awareness Week" to highlight a neurological condition affecting people taking certain medications for mental or gastrointestinal disorders. The resolution aims to raise public and medical awareness about tardive dyskinesia (TD), an involuntary movement disorder impacting approximately 600,000 Americans, with 65% undiagnosed. It encourages individuals to learn about TD symptoms and the importance of monitoring for the condition during long-term medication use. As a symbolic resolution, it has no binding policy effect but seeks to promote recognition of TD in healthcare settings.